HAEMATOLOGICAL MALIGNANCY
Clinical trials for HAEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HAEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HAEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers
Disease control Not yet recruitingThis trial is testing if two already-approved cancer drugs, dabrafenib and trametinib, can help patients with rare cancers or common cancers that have a rare, specific genetic change called a BRAF V600 mutation. The drugs are already used for some cancers like melanoma, but resea…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Study exposes postcode lottery in blood cancer care
Knowledge-focused Not yet recruitingThis study aims to understand why patients with a common, slow-growing blood cancer (chronic lymphocytic leukemia, or CLL) receive different levels of care depending on where they live in the West Midlands region of the UK. Researchers will survey about 130 family doctors and spe…
Matched conditions: HAEMATOLOGICAL MALIGNANCY
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC